Profile of the respiratory failure in immunocompromised patients in the ICU

T. Topalis, P. Vernikos, D. Xanthis, J. Pavleas, A. Skiada, G. Papaspiropoulou, E. Choli, J. Floros (Athens, Greece)

Source: Annual Congress 2010 - Acute respiratory failure
Session: Acute respiratory failure
Session type: Thematic Poster Session
Number: 2292
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstractE-poster

Abstract

Introduction. Immunosuppression, nowdays concerning many patients, poses a major risk factor of respiratory complications including severe acute respiratory failure requiring ICU admission
Patients. Over a 4 year period, 46 patients (21 males, 25 females), 18-89 years old (mean 59) with haematological and rheumatic disorders, all of them considered immunocompromised, were admitted to our ICU due to acute respiratory failure. APACHE II score on admission, underlying disease, type of immunosuppression, blood and bronchial secretions cultures, chest x-ray, length of stay and outcome were recorded.
Results. The underlying disorder was predominantly lymphoma (16/46-34%). Immunosuppression was due to cell mediated immunity impairment following immunosuppressive treatment (mainly corticosteroids-38/46, 82%) and/ or neutropenia (18/46-39%). Respiratory failure was related to infection, pneumonia or sepsis, in 31/46 (67, 4%) and to non-infectious causes, mainly cardiogenic pulmonary oedema, in 15/46 (32.6%). The average APACHE II score was 21.3 (8-31) and diffuse alveolar infiltrates were the main findings in chest x-rays. Bronchial secretions cultures were positive in 25/46 (54.3%) and blood cultures were positive in 17/46 (36.9%). Length of stay was 14.6 days (1-58). Overall mortality was 28/46 (61%), higher in those who were admitted due to infection 22/31 (71%). The main cause of death was multiorgan failure (23/28).
Conclusion. Immunocompromised patients are a group that presents a real challenge for the ICU physician and cumulating experience may play an important role in improving outcome.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Topalis, P. Vernikos, D. Xanthis, J. Pavleas, A. Skiada, G. Papaspiropoulou, E. Choli, J. Floros (Athens, Greece). Profile of the respiratory failure in immunocompromised patients in the ICU. Eur Respir J 2010; 36: Suppl. 54, 2292

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differential characteristics of patients with mild acute respiratory distress syndrome due to community-acquired pneumonia admitted to ICU
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013


Outcomes of noninvasive ventilation in immunosuppressed patients with acute respiratory failure due to pneumonia
Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure
Year: 2018

ICU and twelve-month mortality of patients with acute respiratory failure admitted to the ICU: What is the role of comorbidities?
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014


Outcome of patients with pulmonary fibrosis admitted to the ICU for acute respiratory failure
Source: Eur Respir J 2006; 28: Suppl. 50, 97s
Year: 2006

Hypercapnia as a marker of ICU admission and prolonged hospitalization in patients with community-acquired pneumonia
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015



Characteristics and outcome of COPD patients with an acute exacerbation admited to a respiratory ICU
Source: Annual Congress 2011 - Intensive care outcome
Year: 2011

Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy
Source: Eur Respir J, 54 (1) 1802442; 10.1183/13993003.02442-2018
Year: 2019



Chronic critical illness in patients with acute respiratory failure admitted to a respiratory intensive care unit
Source: International Congress 2018 – Epidemiology and prognostication of critically-ill patients
Year: 2018

Impact of chronic obstructive pulmonary disease in the outcome of intensive care unit-acquired pneumonia
Source: Annual Congress 2013 –COPD and infections
Year: 2013


The use of betablockers in chronic airway disease causing acute respiratory failure in intensive care unit
Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Year: 2013

Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014

Obesity in intensive care unit patients presenting with acute respiratory failure
Source: Annual Congress 2010 - Intensive care unit outcome
Year: 2010


Evaluation of patients with acute respiratory infections hopitalized in a pediatric hospital of Chile
Source: Eur Respir J 2001; 18: Suppl. 33, 294s
Year: 2001

Non-invasive mechanical ventilation and mortality in immunocompromised patients hospitalized with pneumonia
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014

Profile of patients hospitalized with COPD acute exacerbation in respiratory department in Tunisia
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011

1–year mortality in hospitalized patients with an acute exacerbation of COPD on the pulmonary ward compared to the ICU
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015


Concomittant pneumonia in COPD cases admitted to intensive care unit (ICU) with acute respiratory failure (ARF)
Source: Annual Congress 2009 - Acute lung injury and biomarkers
Year: 2009

Community acquired pneumonia in a respiratory ICU
Source: Eur Respir J 2002; 20: Suppl. 38, 475s
Year: 2002